WithdrawnNo phase
A Study of Pregnancy Outcomes in Congenital Heart Disease
Reason given: Lack of funding
Key facts
- Where
- Rochester, United StatesSee the site
Where in United States
- Mayo Clinic in RochesterRochester, United StatesNo longer taking part
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT06678256
- Record updated
- 19 March 2026
- Original description
The purpose of this study is to determine if a biomarker assay obtained peripartum (1st-3rd trimester and post-partum) in patients with adult congenital heart disease can predict future risk of cardiovascular adverse events and determine if temporal changes in biomarkers levels throughout the peripartum period can provide a better risk prediction compared to samples taken at a single time-point.Read full original descriptionShow less
Pregnancy Outcomes in Patients With Adult Congenital Heart Disease
The purpose of this study is to determine if a biomarker assay obtained peripartum (1st-3rd trimester and post-partum) in patients with adult congenital heart disease can predict future risk of cardiovascular adverse events and determine if temporal changes in biomarkers levels throughout the peripartum period can provide a better risk prediction compared to samples taken at a single time-point.
Inclusion: Congenital Heart Disease Diagnosis; Currently Pregnant.
Exclusion: Unable to consent.